243 related articles for article (PubMed ID: 16687990)
1. Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review.
van Liempt S; Vermetten E; Geuze E; Westenberg HG
Int Clin Psychopharmacol; 2006 Jul; 21(4):193-202. PubMed ID: 16687990
[TBL] [Abstract][Full Text] [Related]
2. Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.
Maher MJ; Rego SA; Asnis GM
CNS Drugs; 2006; 20(7):567-90. PubMed ID: 16800716
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of post-traumatic stress disorder.
Ravindran LN; Stein MB
Curr Top Behav Neurosci; 2010; 2():505-25. PubMed ID: 21309124
[TBL] [Abstract][Full Text] [Related]
4. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
Asnis GM; Kohn SR; Henderson M; Brown NL
Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
[TBL] [Abstract][Full Text] [Related]
5. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
6. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder.
Bajor LA; Ticlea AN; Osser DN
Harv Rev Psychiatry; 2011; 19(5):240-58. PubMed ID: 21916826
[TBL] [Abstract][Full Text] [Related]
7. Prazosin in Children and Adolescents With Posttraumatic Stress Disorder Who Have Nightmares: A Systematic Review.
Akinsanya A; Marwaha R; Tampi RR
J Clin Psychopharmacol; 2017 Feb; 37(1):84-88. PubMed ID: 27930498
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.
Davis LL; English BA; Ambrose SM; Petty F
Expert Opin Pharmacother; 2001 Oct; 2(10):1583-95. PubMed ID: 11825301
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature.
van Liempt S; Vermetten E; Geuze E; Westenberg H
Ann N Y Acad Sci; 2006 Jul; 1071():502-7. PubMed ID: 16891608
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.
Berger W; Mendlowicz MV; Marques-Portella C; Kinrys G; Fontenelle LF; Marmar CR; Figueira I
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):169-80. PubMed ID: 19141307
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials.
Sullivan GM; Neria Y
Curr Opin Investig Drugs; 2009 Jan; 10(1):35-45. PubMed ID: 19127485
[TBL] [Abstract][Full Text] [Related]
12. [Antipsychotics, anticonvulsants, antiadrenergics and other drugs: what to do when posttraumatic stress disorder does not respond to selective serotonin reuptake inhibitors?].
Berger W; Portella CM; Fontenelle LF; Kinrys G; Mendlowicz MV
Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S61-5. PubMed ID: 18157435
[TBL] [Abstract][Full Text] [Related]
13. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
Taylor HR; Freeman MK; Cates ME
Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899
[TBL] [Abstract][Full Text] [Related]
14. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials.
Khachatryan D; Groll D; Booij L; Sepehry AA; Schütz CG
Gen Hosp Psychiatry; 2016; 39():46-52. PubMed ID: 26644317
[TBL] [Abstract][Full Text] [Related]
15. Treatment of nightmares with prazosin: a systematic review.
Kung S; Espinel Z; Lapid MI
Mayo Clin Proc; 2012 Sep; 87(9):890-900. PubMed ID: 22883741
[TBL] [Abstract][Full Text] [Related]
16. The effects of prazosin on sleep disturbances in post-traumatic stress disorder: a systematic review and meta-analysis.
Zhang Y; Ren R; Sanford LD; Yang L; Ni Y; Zhou J; Zhang J; Wing YK; Shi J; Lu L; Tang X
Sleep Med; 2020 Mar; 67():225-231. PubMed ID: 31972510
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials.
De Berardis D; Marini S; Serroni N; Iasevoli F; Tomasetti C; de Bartolomeis A; Mazza M; Tempesta D; Valchera A; Fornaro M; Pompili M; Sepede G; Vellante F; Orsolini L; Martinotti G; Di Giannantonio M
Curr Drug Targets; 2015; 16(10):1094-106. PubMed ID: 25944011
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology for sleep disturbance in PTSD.
Lipinska G; Baldwin DS; Thomas KG
Hum Psychopharmacol; 2016 Mar; 31(2):156-63. PubMed ID: 26856810
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for sleep disturbances in post-traumatic stress disorder (PTSD): A network meta-analysis.
Lappas AS; Glarou E; Polyzopoulou ZA; Goss G; Huhn M; Samara MT; Christodoulou NG
Sleep Med; 2024 Jul; 119():467-479. PubMed ID: 38795401
[TBL] [Abstract][Full Text] [Related]
20. Biological therapies for posttraumatic stress disorder: an overview.
Davidson JR
J Clin Psychiatry; 1997; 58 Suppl 9():29-32. PubMed ID: 9329449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
